Leukemia
Advertisement
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, discusses her experiences and shares resources.
Researchers evaluated the renal status of more than 250 patients receiving TKIs in a chronic myeloid leukemia clinic.
Researchers presented the results of the observational study at the 2024 SOHO Meeting.
Research presented at the Annual Meeting of the Society of Hematologic Oncology provided insights on outcomes and risks.
Hear about an NP's journey into hematologic oncology and how she has seen the treatment landscape evolve.
Nurses, nurse administrators, physician assistants, and oncologists/hematologists shared their insights with researchers.
Digital interventions that target physical and mental well-being are needed for adult long-term survivals of ALL.
Nurses may be able to play a role in aligning views between patients and hematologists on prognosis and goals of care.
DSP-5336 is an investigational small-molecule inhibitor of the menin and MLL protein interaction.
It is now “first and only” bispecific T-cell engager therapy approved for consolidation treatment regardless of MRD ...
Hear expert insights on managing treatment for these patients and the key signs and symptoms to monitor.
There is a “lack of consistency” among patient-reported outcome measures used to evaluate CML treatments.
The analysis of 10 clinical trials and 1 prospective cohort study provides a "benchmark for future studies" of the treatment.
A team studied real-world concordance with NCCN guidelines for diagnostic tests, workup during observation, and treatment.
Even highly educated patients feel "inadequately informed about the purpose, implications, and language around testing."
It was important to develop the model because fatigue has been an "overlooked side effect" due to its "subjective nature."
The label expansion was supported by data from the phase III PhALLCON study.
Educational content focused on the pre-HSCT work-up process, chemotherapy, and transplant admission expectations.
The approval is for pediatric patients older than 1 year with relapsed or refractory CD22-positive B-cell precursor ALL.
Nurses reported that they were “keenly aware of how disruptive the environment is for patients and their families."
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.